How Targeted Radiopharmaceuticals Are Driving Nuclear Medicine...

a adăugat un sunet Alte

2026-09-15 06:54:56 -

How Targeted Radiopharmaceuticals Are Driving Nuclear Medicine Market Growth

The nuclear medicine market is entering a period of steady expansion as healthcare systems increasingly adopt precision diagnostics and targeted therapies. The market was valued at USD 21.3 billion in 2025 and is projected to reach USD 38.2 billion by 2033, growing at a 6.8% CAGR from 2026 to 2033. The market is estimated to reach USD 24.1 billion in 2026. Growth is being supported by a robust...

0 Commentarii 0 Distribuiri 59 Views 0 previzualizare